NEW YORK, NY, Opentrons Labworks has announced SoftBank Vision Fund 2 has led the company's $200 million Series C investment with participation by Khosla Ventures.
Opentrons will use this fundraising round to further invest in its automated lab platform globally. Other investors in Opentrons include Sands Capital, Lerer Hippeau Ventures, SOSV, and Y Combinator.
Opentrons develops the integrated lab platform that serves life science and healthcare customers via the Opentrons Robotics, Pandemic Response Lab, and Neochromosome subsidiaries. Opentrons Robotics is a business unit of Opentrons Labworks Inc and is the industry leader in flexible, user-friendly lab automation. Opentrons Robotics flagship product, the OT-2, can be found in thousands of labs in more than 40 countries
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
